Adriamycin is the trade name for the chemoagent doxorubucin and is known by the nickname “red devil,” due to both its deep red color and terrible side effects, which include life-threatening, even fatal damage to the cardiovascular system. This abject lack of “selective CYTOTOXICITY
” — the ability to kill only the cancer cells and not healthy ones – is what makes Adriamycin so dangerous. And yet, it has been a first line treatment for a wide range of cancers for almost half a century.
” — the ability to kill only the cancer cells and not healthy ones – is what makes Adriamycin so dangerous. And yet, it has been a first line treatment for a wide range of cancers for almost half a century.
Since the 1996 study, little research on graviola was performed. There was a cell study in 1999 which showed it had anti- prostate cancer and breast cancer activity; another 2002 cell study showed that graviola exhibited anti-hepatoma (LIVER CANCER) activity, but nothing as promising as the original 1996 study ever followed.
) activity, but nothing as promising as the original 1996 study ever followed.
Then, in 2011, the journal NUTRITION AND CANCER revealed highly promising research on Graviola and breast cancer. Researchers found that graviola fruit extract (GFE) suppressed so-called oncogene (or cancer-causing gene) expression in the cell and animal models of breast cancer. The oncogene known as epidermal growth factor receptor (EGFR) is commonly over-expressed in breast cancer, and therefore an ideal target for therapy.
revealed highly promising research on Graviola and breast cancer. Researchers found that graviola fruit extract (GFE) suppressed so-called oncogene (or cancer-causing gene) expression in the cell and animal models of breast cancer. The oncogene known as epidermal growth factor receptor (EGFR) is commonly over-expressed in breast cancer, and therefore an ideal target for therapy.
No comments:
Post a Comment